These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10728475)

  • 1. Dextrin-2-sulfate. D2S, Emmelle, Viraldon.
    Drugs R D; 1999 Nov; 2(5):340-2. PubMed ID: 10728475
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-HIV type 1 activity of sulfated derivatives of dextrin against primary viral isolates of HIV type 1 in lymphocytes and monocyte-derived macrophages.
    Javan CM; Gooderham NJ; Edwards RJ; Davies DS; Shaunak S
    AIDS Res Hum Retroviruses; 1997 Jul; 13(10):875-80. PubMed ID: 9197381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 124 drugs currently in development.
    AIDS Patient Care STDS; 1998 Feb; 12(2):149. PubMed ID: 11361916
    [No Abstract]   [Full Text] [Related]  

  • 4. AMD 3100. JM 3100, SDZ SID 791.
    Drugs R D; 1999 Nov; 2(5):337-9. PubMed ID: 10728474
    [No Abstract]   [Full Text] [Related]  

  • 5. Adefovir dipivoxil. Bis-POM PMEA, GS 0840, GS 840, Piv2PMEA.
    Drugs R D; 1999 Nov; 2(5):303-5. PubMed ID: 10728465
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug Therapy in HIV Infection--Ninth International Congress.
    Kuritzkes DR
    IDrugs; 2009 Jan; 12(1):20-5. PubMed ID: 19127500
    [No Abstract]   [Full Text] [Related]  

  • 7. Emtricitabine: 524W91, BW524W91, Coviracil, FTC.
    Drugs R D; 2003; 4(1):42-8. PubMed ID: 12568636
    [No Abstract]   [Full Text] [Related]  

  • 8. Second-generation drugs fight resistant virus.
    STEP Perspect; 1999; 99(1):3. PubMed ID: 11367160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentafuside. DP 178, T 20.
    Drugs R D; 1999 Nov; 2(5):347-9. PubMed ID: 10728478
    [No Abstract]   [Full Text] [Related]  

  • 10. Benzimidavir. 1263W94, BW 1263W94, GW 1263.
    Drugs R D; 1999 Nov; 2(5):306-7. PubMed ID: 10728466
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential new therapies for the treatment of HIV-1 infection.
    Condra JH; Miller MD; Hazuda DJ; Emini EA
    Annu Rev Med; 2002; 53():541-55. PubMed ID: 11818489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virodene--support misguided.
    Spencer DC
    S Afr Med J; 1997 May; 87(5):613. PubMed ID: 9254822
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase 2 clinical trials started on PRO 140.
    AIDS Patient Care STDS; 2008 Feb; 22(2):159-60. PubMed ID: 18273941
    [No Abstract]   [Full Text] [Related]  

  • 14. [Revolutionizing HIV-therapy by Tre-Recombinase? Initial observations and current state of development].
    Hauber J; Hauber I; Buchholz F
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():22-3. PubMed ID: 23961648
    [No Abstract]   [Full Text] [Related]  

  • 15. Virodene--support misguided.
    Hugo BW
    S Afr Med J; 1997 May; 87(5):613. PubMed ID: 9254823
    [No Abstract]   [Full Text] [Related]  

  • 16. [HIV therapy of the next generation. Modern active drugs for long-term treatment].
    MMW Fortschr Med; 2012 May; 154 Suppl 1():50-1. PubMed ID: 22916603
    [No Abstract]   [Full Text] [Related]  

  • 17. [Simplification of antiviral therapy with single tablet regimens: advantages and disadvantages of modern ART].
    Spinner CD
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():29-32. PubMed ID: 25026854
    [No Abstract]   [Full Text] [Related]  

  • 18. Preclinical data released on PI.
    AIDS Patient Care STDS; 2003 Sep; 17(9):483-4. PubMed ID: 14596252
    [No Abstract]   [Full Text] [Related]  

  • 19. How Virodene might work--a hypothesis.
    Epstein E
    S Afr Med J; 1998 Feb; 88(2):155-6. PubMed ID: 9717503
    [No Abstract]   [Full Text] [Related]  

  • 20. [Report from San Francisco. An excerpt of the 11th Retrovirus Conference 2004].
    Oette M
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():86-7. PubMed ID: 15373063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.